{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:54Z","timestamp":1791839994564,"version":"4.3.4"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001844","name":"Scleroderma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002350","name":"St. Giles Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00908","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T05:59:04Z","timestamp":1556603944000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":83,"title":["Immunopathogenesis of Pediatric Localized Scleroderma"],"prefix":"10.3389","volume":"10","author":[{"given":"Kathryn S.","family":"Torok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Jacobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Taber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa T.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B2","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmstead County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"B3","first-page":"1004","article-title":"Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease","volume":"33","author":"Scalapino","year":"2006","journal-title":"J Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","article-title":"Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis","volume":"65","author":"Li","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10067-010-1515-2","article-title":"Frequency of antinuclear antibodies in mestizo Mexican children with morphea","volume":"29","author":"Guevara-Gutierrez","year":"2010","journal-title":"Clin. Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/acr.23101","article-title":"Predictors of longitudinal quality of life in juvenile localized scleroderma","volume":"69","author":"Ardalan","year":"2017","journal-title":"Arthritis Care Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphoea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1365-2133.2011.10600.x","article-title":"Misdiagnosis and delay in referral of children with localized scleroderma","volume":"165","author":"Weibel","year":"2011","journal-title":"Br J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/acr2.1019","article-title":"Baseline description of the juvenile localized scleroderma subgroup from the childhood arthritis and rheumatology research alliance legacy registry","volume":"1","author":"Wu","year":"2019","journal-title":"ACR Open Rheumatol In press."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/art.38853","article-title":"Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort","volume":"66","author":"Condie","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12969-018-0252-y","article-title":"Working Towards Comparative Effectiveness Studies for Moderate to Severe Juvenile Localized Scleroderma: Results of a 1-Year Pilot Study of Three Methotrexate-Based Consensus Treatment Plans","volume":"16","author":"Li","year":"","journal-title":"Pediatric Rheumatol Online J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3899\/jrheum.171381","article-title":"New Features for Measuring Disease Activity in Pediatric Localized Scleroderma","volume":"45","author":"Li","year":"","journal-title":"J Rheumatol in press"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/pde.13336","article-title":"Orthopedic complications of linear morphea: Implications for early interdisciplinary care","volume":"35","author":"Schoch","year":"2018","journal-title":"Pediatric Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and parry-romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"B18","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1010-5182(03)00028-3","article-title":"Parry-Romberg syndrome: intracranial MRI appearances","volume":"31","author":"Moko","year":"2003","journal-title":"J Cranio Maxillo Facial Surgery."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma: a case report and literature review","volume":"71","author":"Kister","year":"2008","journal-title":"Neurology."},{"key":"B21","first-page":"64","article-title":"Severe epilepsy preceding by four months the onset of scleroderma en coup de sabre","volume":"27","author":"Sartori","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00431-015-2532-6","article-title":"Overlap between linear scleroderma, progressive facial hemiatrophy and immune-inflammatory encephalitis in a paediatric cohort","volume":"174","author":"De Somer","year":"2015","journal-title":"Eur J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF00315664","article-title":"Progressive inflammatory lesions of the brain parenchyma in localized scleroderma of the head","volume":"237","author":"Luer","year":"1990","journal-title":"J Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jpeds.2004.10.026","article-title":"Parry-Romberg syndrome with fatal brain stem involvement","volume":"146","author":"Sathornsumetee","year":"2005","journal-title":"J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.70.3.382","article-title":"Scleroderma \u201cen coup de sabre\u201d: pathological evidence of intracerebral inflammation","volume":"70","author":"Stone","year":"2001","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/bjd.12758","article-title":"Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients","volume":"170","author":"Pequet","year":"2014","journal-title":"Br J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/j.1365-4632.2006.02891.x","article-title":"Antihistone antibodies in linear scleroderma variants","volume":"45","author":"el-Azhary","year":"2006","journal-title":"Int. J. Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1002\/art.38814","article-title":"Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the morphea in adults and children cohort","volume":"66","author":"Jacobe","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/art.24328","article-title":"Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions","volume":"60","author":"Hemminki","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000452949","article-title":"The puzzle of the skin patterns","volume":"4","author":"Tenea","year":"2017","journal-title":"Integr Med Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1346-8138.2010.01162.x","article-title":"Digital image processing for the acquisition of graphic similarity of the distributional patterns between cutaneous lesions of linear scleroderma and Blaschko's lines","volume":"38","author":"Jue","year":"2011","journal-title":"J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-2133.2008.08647.x","article-title":"Linear morphoea follows blaschko's lines","volume":"159","author":"Weibel","year":"2008","journal-title":"Br J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.clindermatol.2010.09.012","article-title":"Blaschko lines and other patterns of cutaneous mosaicism","volume":"29","author":"Molho-Pessach","year":"2011","journal-title":"Clin Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/jid.2012.379","article-title":"Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus","volume":"133","author":"Levinsohn","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1212\/WNL.48.4.1013","article-title":"Progressive facial hemiatrophy and epilepsy: a common underlying dysgenetic mechanism","volume":"48","author":"Dupont","year":"1997","journal-title":"Neurology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.410370519","article-title":"Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings","volume":"37","author":"Chung","year":"1995","journal-title":"Ann Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1055\/s-2007-979779","article-title":"Progressive facial hemiatrophy with multiple benign tumors and hamartomas","volume":"26","author":"Derex","year":"1995","journal-title":"Neuropediatrics."},{"key":"B41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jaad.2016.12.020","article-title":"Histopathological changes in morphea and their clinical correlates: results from the morphea in adults and children cohort V","volume":"76","author":"Walker","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s002340050525","article-title":"Parry-Romberg syndrome: follow-up imaging during suppressive therapy","volume":"39","author":"Goldberg-Stern","year":"1997","journal-title":"Neuroradiology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1542\/peds.2005-0470","article-title":"Linear scleroderma en coup de sabre with associated neurologic abnormalities","volume":"117","author":"Holland","year":"2006","journal-title":"Pediatrics."},{"key":"B45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3899\/jrheum.110210","article-title":"Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study","volume":"39","author":"Torok","year":"2012","journal-title":"J Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/00006534-199005000-00001","article-title":"Clinical and ultrastructural studies of Romberg's hemifacial atrophy","volume":"85","author":"Pensler","year":"1990","journal-title":"Plast Reconstr Surg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00234-014-1448-6","article-title":"CNS imaging findings associated with Parry-Romberg syndrome and en coup de sabre: correlation to dermatologic and neurologic abnormalities","volume":"57","author":"Doolittle","year":"2015","journal-title":"Neuroradiology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jaad.2012.04.003","article-title":"Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center","volume":"67","author":"Kreuter","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/art.1780390624","article-title":"Childhood-onset scleroderma: is it different from adult-onset disease","volume":"39","author":"Vancheeswaran","year":"1996","journal-title":"Arthritis Rheum"},{"key":"B51","unstructured":"Autoantibody testing in pediatric localized scleroderma (LS) PorterA MirizioE FritzlerMJ BrownR ChoiM Schollaert-FitchK Arthritis Rheumatol702018"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/archdermatol.2009.235","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus","volume":"145","author":"Kreuter","year":"2009","journal-title":"Arch Dermatol"},{"key":"B53","first-page":"171","article-title":"Localized scleroderma in adults and children","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1529-8019.2012.01479.x","article-title":"Localized scleroderma","volume":"25","author":"Kreuter","year":"2012","journal-title":"Dermatol Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17312","article-title":"Prediction of disease relapse in a cohort of juvenile localized scleroderma patients","author":"Kurzinski","year":"2018","journal-title":"Br J Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamadermatol.2013.4207","article-title":"Morphea in adults and children cohort III: nested case-control study\u2013the clinical significance of autoantibodies in morphea","volume":"149","author":"Dharamsi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"849","DOI":"10.7326\/0003-4819-104-6-849","article-title":"Linear scleroderma","volume":"104","author":"Falanga","year":"1986","journal-title":". Ann Intern Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/art.1780370313","article-title":"Antihistone antibodies in systemic sclerosis","volume":"37","author":"Sato","year":"1994","journal-title":"Assoc Pulmonary Fibrosis Arthritis Rheum"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"B60","first-page":"650","article-title":"Localized scleroderma severity index and global assessments: a pilot study of outcome instruments","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"B61","first-page":"264","article-title":"Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma)","volume":"97","author":"Inoshita","year":"1981","journal-title":"J Lab Clin Med"},{"key":"B62","first-page":"443","article-title":"Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies","volume":"48","author":"Keystone","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jid.2018.09.025","article-title":"Identifying the signature immune phenotypes present in pediatric localized scleroderma","volume":"139","author":"Mirizio","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.clim.2013.07.005","article-title":"T lymphocyte abnormalities in juvenile systemic sclerosis patients","volume":"149","author":"Reiff","year":"2013","journal-title":"Clin Immunol"},{"key":"B65","unstructured":"Multiparameter mass cytometry by time-of-flight spectrometry (CyTOF) phenotyping in pediatric localized scleroderma [abstract] MirizioE MellinsED MacaubasC MaeckerHT GartnerF KonnikovaL Arthritis Rheumatol70"},{"key":"B66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.semarthrit.2015.06.006","article-title":"Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles","volume":"45","author":"Torok","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jid.2017.04.008","article-title":"Transcriptional and cytokine profiles identify CXCL9 as a biomarker of disease activity in morphea","volume":"137","author":"O'Brien","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B68","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archderm.1994.01690100117021","article-title":"Demonstration of interleukin 8 in serum samples of patients with localized scleroderma","volume":"130","author":"Ihn","year":"1994","journal-title":"Arch Dermatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01262331","article-title":"Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma","volume":"287","author":"Ihn","year":"1995","journal-title":"Arch Dermatol Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000071783","article-title":"Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma","volume":"207","author":"Hasegawa","year":"2003","journal-title":"Dermatology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1546-0096-5-22","article-title":"Increased serum levels of TGFbeta1 in children with localized scleroderma","volume":"5","author":"Uziel","year":"2007","journal-title":"Pediatr Rheumatol Online J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5114\/pdia.2015.48044","article-title":"Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma","volume":"33","author":"Budzynska-Wlodarczyk","year":"2016","journal-title":"Postepy Dermatol Alergol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/art.1780370618","article-title":"Serum levels of soluble interleukin-2 receptor","volume":"37","author":"Uziel","year":"1994","journal-title":". Arthritis Rheum"},{"key":"B74","first-page":"1917","article-title":"Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma","volume":"27","author":"Nagaoka","year":"2000","journal-title":"J Rheumatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.5114\/aoms.2012.32421","article-title":"Interleukin-17A and interleukin-23 in morphea","volume":"8","author":"Danczak-Pazdrowska","year":"2012","journal-title":"Arch Med Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jid.2017.11.032","article-title":"Regarding \u201ctranscriptional and cytokine profiles identify CXCL9 as a biomarker of disease activity in morphea\u201d","volume":"138","author":"Mertens","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"R188","DOI":"10.1186\/ar4378","article-title":"Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma","volume":"15","author":"Magee","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B78","unstructured":"Chemokine ligand 9 (CXCL9) [monokine induced by gamma interferon (MIG)] as a predictor of active disease status in localized scleroderma [abstract] TorokKS MiQ MirizioE Schollaert-FitchK FritzlerM FritzlerMJ Arthritis Rheumatol692017"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.regpep.2011.05.003","article-title":"Significantly increased CCL5\/RANTES and CCR7 mRNA levels in localized scleroderma","volume":"170","author":"Gambichler","year":"2011","journal-title":"Regul Pept"},{"key":"B80","unstructured":"Nterferon gamma (IFN-\u03b3) Subpopulations in skin homing T cells of localized scleroderma [abstract] MacaubasC MirizioE Schollaert-FitchK MellinsED TorokKS Arthritis Rheumatol692017"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.jid.2016.11.037","article-title":"Skin-resident effector memory CD8(+)CD28(-) T cells exhibit a profibrotic phenotype in patients with systemic sclerosis","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS ONE."},{"key":"B83","unstructured":"Genetic signatures from RNA sequencing of pediatric localized scleroderma (LS) skin MirizioE MandalR YanQ HorneW Schollaert-FitchK TorokKS Arthritis Rheumatol70"},{"key":"B84","unstructured":"Machine learning classification of peripheral blood gene expression identifies a subset of patients with systemic sclerosis most likely to show clinical improvement in response to hematopoietic stem cell transplant FranksJ MartyanovV WoodTA CroordL Keyes-ElsteinL FurstDE Arthritis Rheumatol.902018"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/jid.2013.130","article-title":"Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis","volume":"133","author":"Hinchcliff","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.cell.2018.06.045","article-title":"Stereotypic immune system development in newborn children","volume":"174","author":"Olin","year":"2018","journal-title":"Cell."},{"key":"B87","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/sji.12413","article-title":"Effects of ageing on the immune system: infants to elderly","volume":"83","author":"Valiathan","year":"2016","journal-title":"Scand J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1373\/clinchem.2015.240531","article-title":"Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian health measures survey","volume":"61","author":"Adeli","year":"2015","journal-title":"Clin Chem"},{"key":"B90","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3389\/fimmu.2017.00957","article-title":"Postnatal innate immune development: from birth to adulthood","volume":"8","author":"Georgountzou","year":"2017","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/smim.1999.0163","article-title":"The physiology of lymphocyte migration through the single lymph node in vivo","volume":"11","author":"Young","year":"1999","journal-title":"Semin Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.immuni.2017.03.009","article-title":"Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny","volume":"46","author":"Kollmann","year":"2017","journal-title":"Immunity."},{"key":"B93","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4049\/jimmunol.150.5.2033","article-title":"Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins","volume":"150","author":"Hawes","year":"1993","journal-title":"J Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molmed.2007.01.005","article-title":"Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated disease","volume":"13","author":"Vallejo","year":"2007","journal-title":"Trends Mol Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels","year":"2010","journal-title":"Arch Dermatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.autrev.2018.02.004","article-title":"Disease course and long-term outcome of juvenile localized scleroderma: experience from a single pediatric rheumatology centre and literature review","volume":"17","author":"Martini","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00908\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:28:10Z","timestamp":1694827690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00908\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2019.00908"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00908","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"article-number":"908"}}